How ASPEC Work-Sharing Operates<\/strong><\/p>\n\n\n\nASPEC is a patent work-sharing framework involving nine participating ASEAN intellectual property offices which operates in English. It allows an IP office to consider eligible search and examination results issued by another participating IP office when examining a corresponding patent application.<\/p>\n\n\n\n
When a Singapore application receives a report identifying at least one allowable claim, the applicant may use that result to request ASPEC acceleration for a corresponding application, subject to the requirements of the second office.<\/p>\n\n\n\n
What ASPEC Does Not Provide<\/strong><\/p>\n\n\n\nASPEC does not create a single ASEAN patent. Applicants must still file in each intended jurisdiction and remain responsible for local filing, prosecution, translation, professional, and renewal costs.<\/p>\n\n\n\n
ASPEC can reduce duplicated examination work and support more coordinated prosecution, but it does not guarantee allowance or a particular grant date.<\/p>\n\n\n\n
<\/div>\n\n\n\n
ASPEC, ASPEC+, PPH, and Accelerated Grant Strategies<\/strong><\/p>\n\n\n\nComparing the Available Routes<\/strong><\/p>\n\n\n\nASPEC is designed for corresponding applications within participating ASEAN jurisdictions. PPH Singapore generally relies on allowable or patentable claims identified by a participating foreign patent office, while SG Patents Fast accelerates eligible domestic examination before IPOS.<\/p>\n\n\n\n
ASPEC+ was launched on 6 April 2026 as an additional option under the established ASPEC framework. It aims to provide more closely harmonised patent reports and committed timelines, giving applicants greater predictability when planning regional protection. The main difference between ASPEC and ASPEC+ is that with ASPEC examination in respective countries is sequential, whereas with ASPEC+, it is carried out at the same time (in parallel).<\/p>\n\n\n\n
Current Singapore Acceleration Position<\/strong><\/p>\n\n\n\nAlthough IPOS Circular 1\/2026 temporarily suspended the acceptance of new SG Patents Fast requests from 4 January 2026. The suspension was lifted on 1 September 2026. Accordingly, SG Patents Fast 4 and Fast 8 is available alongside the PPH and ASPEC.<\/p>\n\n\n\n
A registered patent agent in Singapore can assess which route offers the appropriate balance of speed, cost, claim quality, and long-term enforceability.<\/p>\n\n\n\n
Control Claims Before Examination<\/strong><\/p>\n\n\n\nApplicants should review their claims before requesting search or examination. Removing duplication and prioritising commercially important claims can reduce official fees, although cost control should not weaken necessary protection. This is because SG Patents Fast 4 and Fast 8 only allow up to 20 claims and excess claims fees become payable after 15 claims.<\/p>\n\n\n\n
<\/div>\n\n\n\n
Sector-Specific Considerations for ASEAN Patent Expansion<\/strong><\/p>\n\n\n\n\n- MedTech<\/strong><\/li>\n<\/ol>\n\n\n\n
MedTech patent strategies should account for product development, regulatory submissions, and commercial rollout schedules. ASPEC may help coordinate prosecution, but patent examination and regulatory approval remain separate processes.<\/p>\n\n\n\n
\n- Green Technology<\/strong><\/li>\n<\/ol>\n\n\n\n
Green-technology applications often contain device, system, process, and control claims. Applicants should maintain sufficient consistency across ASEAN filings while adapting the claims to national patentability practices.<\/p>\n\n\n\n
\n- Biotechnology<\/strong><\/li>\n<\/ol>\n\n\n\n
Biotech intellectual property may face different exclusions and examination approaches across ASEAN jurisdictions. A favourable Singapore examination result can support ASPEC work-sharing, but each office will still assess the application under its own law.<\/p>\n\n\n\n
Leveraging Enterprise Innovation Scheme Incentives<\/strong><\/p>\n\n\n\nEligible businesses may claim a 400% deduction on the first S$400,000 of qualifying IP registration costs per Year of Assessment from 2024 to 2028. Eligibility and expenditure conditions apply, so businesses should confirm their position with a qualified tax adviser.<\/p>\n\n\n\n
<\/div>\n\n\n\n
Why Choosing the Right Patent Partner Matters<\/strong><\/p>\n\n\n\nRegional Coordination and Execution<\/strong><\/p>\n\n\n\nASPEC ASEAN filing is not a plug-and-play system. Its effectiveness depends on the quality of the originating examination result, correspondence between applications, supporting documents, and coordination of national deadlines.<\/p>\n\n\n\n
An experienced patent firm can assist with:<\/p>\n\n\n\n
\n- Preparing claims for Singapore and regional use;<\/li>\n\n\n\n
- Evaluating ASPEC, ASPEC+, PPH, and domestic acceleration;<\/li>\n\n\n\n
- Coordinating applications with local ASEAN associates;<\/li>\n\n\n\n
- Managing examination responses and claim amendments;<\/li>\n\n\n\n
- Monitoring official fees and excess-claim exposure; and<\/li>\n\n\n\n
- Aligning prosecution with licensing and expansion plans<\/li>\n<\/ul>\n\n\n\n
A registered patent agent with regional experience can anticipate procedural differences and reduce avoidable inconsistencies across the portfolio.<\/p>\n\n\n\n
Building a Sustainable ASEAN Patent Portfolio From Singapore<\/strong><\/p>\n\n\n\nSecuring patents across ASEAN is not simply about filing everywhere as quickly as possible. It requires a defendable and commercially aligned portfolio covering the markets where protection supports manufacturing, sales, licensing, or investment.<\/p>\n\n\n\n
Singapore provides the filing and examination foundation, while ASPEC provides regional work-sharing leverage. When these elements are coordinated carefully, companies can pursue greater prosecution efficiency without sacrificing claim quality.<\/p>\n\n\n\n
<\/div>\n\n\n\n
Frequently Asked Questions<\/strong><\/p>\n\n\n\nWhat is ASPEC ASEAN filing?<\/strong><\/p>\n\n\n\nASPEC is a work-sharing programme that allows participating ASEAN patent offices to consider eligible search and examination results from another participating office. It can support accelerated examination of corresponding national patent applications.<\/p>\n\n\n\n
Does ASPEC provide one patent covering all ASEAN countries?<\/strong><\/p>\n\n\n\nNo. ASPEC does not create a regional patent or replace national patent applications. Protection must still be obtained separately in each selected jurisdiction.<\/p>\n\n\n\n
What is generally required for an ASPEC request?<\/strong><\/p>\n\n\n\nCorresponding applications for the same invention must generally exist in at least two participating jurisdictions. The supporting examination result should identify at least one allowable claim, subject to the receiving office\u2019s requirements.<\/p>\n\n\n\n
What is the difference between ASPEC and PPH Singapore?<\/strong><\/p>\n\n\n\nASPEC is regional whereas PPH operates worldwide. Patent claims in later ASPEC countries can be more flexible, whereas later PPH claims must generally be identical or narrower in scope ASPEC operates entirely in English, whereas the PPH may not (depending on which countries you choose).<\/p>\n\n\n\n
Does ASPEC remove local patent filing fees?<\/strong><\/p>\n\n\n\nNo. Applicants remain responsible for national filing, examination, translation, professional, and renewal costs. ASPEC facilitates work-sharing but does not create a fee-free regional filing route.<\/p>\n\n\n\n
Conclusion<\/strong><\/p>\n\n\n\nASPEC can help businesses coordinate patent examination across participating ASEAN markets from a Singapore filing base. Careful claim preparation, route selection, and regional management remain essential because every patent right is ultimately examined and granted nationally.<\/p>","protected":false},"excerpt":{"rendered":"
Expanding patent protection beyond Singapore is no longer a future consideration for innovative companies. It is now a strategic necessity. With ASEAN markets growing in MedTech, biotechnology, green technology, and advanced manufacturing, securing regional patent rights efficiently has become a core business decision rather than a legal afterthought. Singapore provides a strong regional filing base, […]<\/p>","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"cybocfi_hide_featured_image":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[20,159],"tags":[],"class_list":["post-38226","post","type-post","status-publish","format-standard","hentry","category-articles","category-patent-protection"],"acf":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/posts\/38226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/comments?post=38226"}],"version-history":[{"count":1,"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/posts\/38226\/revisions"}],"predecessor-version":[{"id":38227,"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/posts\/38226\/revisions\/38227"}],"wp:attachment":[{"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/media?parent=38226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/categories?post=38226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pintas-ip.com\/cn\/wp-json\/wp\/v2\/tags?post=38226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}